X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (122) 122
oncology (81) 81
male (80) 80
female (79) 79
middle aged (72) 72
adult (67) 67
aged (63) 63
index medicus (48) 48
cancer (36) 36
melanoma - drug therapy (36) 36
melanoma (28) 28
animals (27) 27
chemotherapy (25) 25
antineoplastic agents - therapeutic use (19) 19
melanoma - pathology (19) 19
adolescent (18) 18
care and treatment (18) 18
neoplasms - drug therapy (17) 17
survival (16) 16
immunotherapy (15) 15
prognosis (15) 15
research (15) 15
treatment outcome (15) 15
mice (14) 14
hematology, oncology and palliative medicine (13) 13
immunology (13) 13
lung neoplasms - drug therapy (13) 13
microbiology (13) 13
time factors (13) 13
aged, 80 and over (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
drug administration schedule (12) 12
expression (12) 12
pharmacology & pharmacy (12) 12
skin neoplasms - drug therapy (12) 12
dose-response relationship, drug (11) 11
health aspects (11) 11
melanoma - therapy (11) 11
metastatic melanoma (11) 11
pharmacokinetics (11) 11
therapy (11) 11
young adult (11) 11
medicine & public health (10) 10
melanoma - secondary (10) 10
neoplasm staging (10) 10
skin neoplasms - pathology (10) 10
survival analysis (10) 10
analysis (9) 9
bacteria (9) 9
cancer research (9) 9
carcinoma (9) 9
carcinoma, non-small-cell lung - drug therapy (9) 9
drug therapy (9) 9
gene-expression (9) 9
medicine (9) 9
mice, nude (9) 9
neoplasm metastasis (9) 9
neoplasm transplantation (9) 9
research article (9) 9
virulence (9) 9
antineoplastic agents - administration & dosage (8) 8
antineoplastic agents - adverse effects (8) 8
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
biofilms (8) 8
biofilms - drug effects (8) 8
clinical trials (8) 8
combined modality therapy (8) 8
dental plaque (8) 8
disease-free survival (8) 8
infusions, intravenous (8) 8
lung neoplasms - pathology (8) 8
malignant-melanoma (8) 8
melanoma - immunology (8) 8
melanoma - mortality (8) 8
solid tumors (8) 8
transplantation, heterologous (8) 8
anti-bacterial agents - pharmacology (7) 7
antineoplastic agents (7) 7
breast-cancer (7) 7
cancer and oncology (7) 7
cancer och onkologi (7) 7
cancer vaccines - immunology (7) 7
cisplatin - administration & dosage (7) 7
dacarbazine - administration & dosage (7) 7
dendritic cells (7) 7
dentistry, oral surgery & medicine (7) 7
escherichia-coli (7) 7
gene expression (7) 7
medicine, research & experimental (7) 7
melanoma - genetics (7) 7
neoplasms - metabolism (7) 7
neoplasms - pathology (7) 7
quality of life (7) 7
quorum sensing - drug effects (7) 7
antibiotics (6) 6
biofilm formation (6) 6
cancer vaccines - therapeutic use (6) 6
clinical trial (6) 6
dentistry (6) 6
docetaxel (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Tidsskrift for den Norske Laegeforening, ISSN 0029-2001, 10/2001, Volume 121, Issue 26, pp. 3066 - 3071
Journal Article
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 11/2011, Volume 9, Issue 1, pp. 204 - 204
Background: Ipilimumab, a fully human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4, has demonstrated an improvement in overall survival in... 
Tumor biomarker | Cytotoxic t-lymphocyte antigen-4 | Tumor-infiltrating lymphocytes | Ipilimumab | Melanoma | Indoleamine 2,3-dioxygenase | Foxp3 | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | SOLID TUMORS | INFILTRATING LYMPHOCYTES | Cytotoxic T-lymphocyte antigen-4 | melanoma | PERIPHERAL-BLOOD | OVARIAN-CARCINOMA | PROGNOSTIC-FACTOR | THERAPY | ipilimumab | REGULATORY T-CELLS | tumor-infiltrating lymphocytes | indoleamine 2,3-dioxygenase | FoxP3 | tumor biomarker | ABSOLUTE LYMPHOCYTE COUNT | Immunohistochemistry | Prospective Studies | Skin Neoplasms - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | RNA, Messenger - metabolism | Dose-Response Relationship, Drug | Young Adult | Antineoplastic Agents - adverse effects | Melanoma - genetics | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Skin Neoplasms - pathology | Tumor Microenvironment - drug effects | Drug Administration Schedule | Antibodies, Monoclonal - pharmacology | RNA, Messenger - genetics | Treatment Outcome | Melanoma - pathology | Polymorphism, Genetic | Antibodies, Monoclonal - administration & dosage | Melanoma - drug therapy | Skin Neoplasms - genetics | Aged | Neoplasm Staging | Usage | Messenger RNA | Physiological aspects | Genetic aspects | Research | Biological markers | Gene expression | Studies | Clinical trials | Medical research | Cancer
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2017, Volume 28, Issue suppl_5
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2011, Volume 47, Issue 3, pp. S336 - S337
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 2, pp. 144 - 152
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 9/2013, Volume 62, Issue 9, pp. 1499 - 1509
Journal Article
by Fox, BA and Schendel, D.J and Butterfield, L.H and Aamdal, S and Allison, J.P and Ascierto, P.A and Atkins, M.B and Bartunkova, J and Bergmann, L and Berinstein, N and Bonorino, C.C and Borden, E and Bramson, J.L and Britten, C.M and Cao, X and Carson, W.E and Chang, A.E and Characiejus, D and Choudhury, A.R and Coukos, G and de Gruijl, T.D and Dillman, R.O and Dolstra, H and noff, G and Durrant, L.G and Finke, J.H and Galon, J and Gollob, J.A and Gouttefangeas, C and Grizzi, F and Guida, M and Hakansson, L and Hege, K and Herberman, R.B and Hodi, F.S and Hoos, A and Huber, C and Hwu, P and Imai, K and Jaffee, E.M and Janetzki, S and June, C.H and Kalinski, P and Kaufmann, H.L and Kawakami, K and Kawakami, Y and Keilholtz, U and Khleif, S.N and Kiessling, R and Kotlan, B and Kroemer, G and Lapointe, R and Levitsky, H.I and Lotze, M.T and Di Maio, M and Marschner, J.P and Mastrangelo, M.J and Masucci, G and Melero, I and Nelief, C and Murphy, W.J and Nelson, B and Nicolini, A and Nishimura, M.I and Odunsi, K and Ohashi, P.S and O'Donnell-Tormey, J and Old, L.J and Ottensmeier, C and Papamichail, M and Parmiani, G and Pawelec, G and Proietti, E and Qin, S and Rees, R and Ribas, A and Ridolfi, R and Ritter, G and Rivoltini, L and Romero, P.J and Salem, M.L and Scheper, R.J and Seliger, B and Sharma, P and Shiku, H and Singh-Jasuja, H and Song, W and Straten, P.T and Tahara, H and Tian, Z and van der Burg, S.H and von Hoegen, P and Wang, E and Welters, M.J and Winter, H and Withington, T and Wolchok, J.D and Xiao, W and Zitvogel, L and Zwierzina, H and ...
Journal of Translational Medicine, ISSN 1479-5876, 2011, Volume 9, Issue 1, pp. 214 - 214
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2014, Volume 134, Issue 1, pp. 102 - 113
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 6/2011, Volume 60, Issue 6, pp. 809 - 818
Immunotherapy targeting the hTERT subunit of telomerase has been shown to induce robust immune responses in cancer patients after vaccination with single hTERT... 
Immunology | Medicine & Public Health | Epitope identification | Pancreas cancer | Cancer Research | Oncology | Telomerase (hTERT) | Dendritic cell vaccination | CD8(+) | PHASE-I/II | INDUCTION | IMMUNOLOGY | IDENTIFICATION | TUMOR-ANTIGEN | MELANOMA | ONCOLOGY | GENERATION | TELOMERASE PEPTIDE VACCINATION | T-CELLS | CROSS-PRESENTATION | Cell Growth Processes - immunology | RNA, Messenger - immunology | Dendritic Cells - immunology | Humans | Middle Aged | Telomerase - immunology | Carcinoma, Pancreatic Ductal - genetics | Cancer Vaccines - genetics | Epitopes - immunology | Cancer Vaccines - therapeutic use | Telomerase - genetics | Transfection | Female | Carcinoma, Pancreatic Ductal - immunology | T-Lymphocytes, Cytotoxic - immunology | Pancreatic Neoplasms - pathology | RNA, Messenger - genetics | Pancreatic Neoplasms - genetics | Carcinoma, Pancreatic Ductal - therapy | Epitopes - genetics | Carcinoma, Pancreatic Ductal - pathology | Cancer Vaccines - immunology | T-Lymphocytes, Cytotoxic - metabolism | Pancreatic Neoplasms - immunology | Cell Line, Tumor | Pancreatic Neoplasms - therapy | Care and treatment | Peptides | Dendritic cells | Vaccination | Oncology, Experimental | Research | T cells | Pets | Chemotherapy | Messenger RNA | Analysis | Pancreatic cancer | Telomerase | Antigenic determinants | Cancer | Adenocarcinoma | Immune response | Cytotoxicity | Lymphocytes T | mRNA | Epitopes | Vaccines | Radicals | Computed tomography | Immunotherapy | Surgery | Remission | gemcitabine | telomerase reverse transcriptase | Neutropenia | Original
Journal Article
Journal Article